Pornpen Srisawasdi
Overview
Explore the profile of Pornpen Srisawasdi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sriphrapradang C, Srisawasdi P, Shantavasinkul P, Auparakkitanon S, Krongvorakul J, Punprasit S, et al.
J Clin Lipidol
. 2024 Nov;
19(1):162-166.
PMID: 39586762
Pseudohypertriglyceridemia is an overestimation of serum triglyceride levels, potentially leading to an inaccurate diagnosis of hypertriglyceridemia. This can result from hyperglycerolemia, which interferes with enzymatic measurement methods. Hyperglycerolemia may arise...
2.
Choochuay K, Kunhapan P, Puangpetch A, Tongsima S, Srisawasdi P, Sobhonslidsuk A, et al.
World J Hepatol
. 2024 Apr;
16(3):366-378.
PMID: 38577531
Background: The prevalence of metabolic-associated fatty liver disease (MAFLD) is a growing public health issue in people living with human immunodeficiency virus (PLWH). However, the pathophysiology of MAFLD is still...
3.
Atasilp C, Kanjanapipak J, Vichayaprasertkul J, Jinda P, Tiyasirichokchai R, Srisawasdi P, et al.
BMC Pediatr
. 2022 May;
22(1):243.
PMID: 35501760
Hyperbilirubinemia is the main mechanism that causes neonatal jaundice, and genetics is one of the risk factors of hyperbilirubinemia. Therefore, this study aims to explore the correlation between two genes,...
4.
Vanwong N, Tipnoppanon S, Na Nakorn C, Srisawasdi P, Rodcharoen P, Medhasi S, et al.
Pharmgenomics Pers Med
. 2022 Feb;
15:119-130.
PMID: 35210819
Purpose: Statins are increasingly widely used in the primary and secondary prevention of cardiovascular disease. However, there is an inter-individual variation in statin response among patients. The study aims to...
5.
Srisawasdi P, Rodcharoen P, Vanavanan S, Chittamma A, Sukasem C, Na Nakorn C, et al.
Pharmgenomics Pers Med
. 2021 Jan;
14:1-13.
PMID: 33447072
Objective: Patients treated with statins for dyslipidemia may still have a residual risk of atherosclerotic cardiovascular disease (ASCVD). To determine whether genetic variants in the cholesteryl ester transport protein (CETP),...
6.
Na Nakorn C, Waisayarat J, Dejthevaporn C, Srisawasdi P, Wongwaisayawan S, Sukasem C
Front Pharmacol
. 2020 Jun;
11:728.
PMID: 32581780
Aim: To investigate the variations and the frequencies of the gene in the Thai population. Methods: Collected samples were categorized into five regions of Thailand. DNA samples were genotyped for...
7.
Puangpetch A, Srisawasdi P, Unaharassamee W, Jiratjintana N, Vanavanan S, Punprasit S, et al.
Pharmgenomics Pers Med
. 2019 Sep;
12:155-166.
PMID: 31496784
Objective: To determine whether genetic polymorphisms related to pharmacodynamics with metabolic adverse effects, namely leptin promoter () rs7799039, leptin receptor rs1137101, dopamine D2 rs4436578, serotonin 5-HT2A rs6313, and serotonin 5-HT2C...
8.
Vanavanan S, Srisawasdi P, Rochanawutanon M, Kumproa N, Kruthkul K, Kroll M
Diabetes Metab Syndr Obes
. 2018 Jun;
11:241-253.
PMID: 29910627
Background: Body mass index (BMI) and percentage of body fat (PBF) are used to measure obesity; however, their performance in identifying cardiometabolic risk in Southeast Asians is unclear. Generally, Asian...
9.
Sukasem C, Vanwong N, Srisawasdi P, Ngamsamut N, Nuntamool N, Hongkaew Y, et al.
Basic Clin Pharmacol Toxicol
. 2018 Jan;
123(1):42-50.
PMID: 29369497
The purpose of this study was to explore the association of genetic polymorphism of genes related to pharmacokinetics or pharmacodynamics with insulin resistance in children and adolescents with autism spectrum...
10.
Srisawasdi P, Vanwong N, Hongkaew Y, Puangpetch A, Vanavanan S, Intachak B, et al.
Clin Biochem
. 2017 Feb;
50(12):678-685.
PMID: 28167244
Objective: To evaluate the influence of dose and duration of risperidone treatment on cardiovascular and diabetes risk biomarkers in children and adolescents with autistic spectrum disorders (ASDs). Design And Methods:...